Ticker

Analyst Price Targets — PK

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
June 18, 2026 10:13 amWells Fargo$15.00$14.50TheFly Park Hotels & Resorts price target raised to $15 from $12 at Wells Fargo
June 12, 2026 11:59 amBMO Capital$14.00$14.47TheFly Park Hotels & Resorts price target raised to $14 from $11 at BMO Capital
June 1, 2026 9:57 amBarclays$12.00$12.13TheFly Park Hotels & Resorts price target raised to $12 from $9 at Barclays
February 3, 2026 1:51 pmTruist Financial$11.00$11.10TheFly Park Hotels & Resorts price target lowered to $11 from $12 at Truist
January 16, 2026 12:29 pmMorgan Stanley$10.00$11.49TheFly Park Hotels & Resorts price target lowered to $10 from $12 at Morgan Stanley
January 6, 2026 10:06 amBarclays$13.00$10.57TheFly Park Hotels & Resorts initiated with an Overweight at Barclays
December 4, 2025 12:17 pmTruist Financial$12.00$10.69TheFly Park Hotels & Resorts price target raised to $12 from $11 at Truist
November 20, 2025 1:07 pmDuane PfennigwerthEvercore ISI$12.00$10.03TheFly Park Hotels & Resorts price target lowered to $12 from $13 at Evercore ISI
October 6, 2025 1:39 pmRobin FarleyUBS$11.00$10.93TheFly Park Hotels & Resorts price target raised to $11 from $10 at UBS
October 1, 2025 9:48 amCantor Fitzgerald$12.00$11.08TheFly Park Hotels & Resorts initiated with a Neutral at Cantor Fitzgerald

Latest News for PK

This High-Dividend Real Estate ETF Holds Some Bargains

Even without rate cut assistance from the Federal Reserve, the real estate sector is delivering the goods for investors this year. Count the ALPS REIT Dividend Dogs ETF (RDOG) among the real estate ETFs displaying leadership traits.

ETF Trends • Jul 9, 2026
Park Hotels & Resorts: This Rally May Not Be Over

Park Hotels & Resorts remains a Buy, offering a compelling margin of safety and attractive valuation despite a 30% stock rally. Q1 results exceeded expectations, with RevPAR up 2.2% YoY, and ongoing renovations are expected to drive further improvements later on. PK's disciplined asset sales and portfolio optimization strengthen its balance sheet amid elevated leverage and support their renovations, offering a…

Seeking Alpha • Jul 3, 2026
Javelin Biotech and Pfizer Announce Landmark Publication Demonstrating Clinical PK Predictions Using Multi-Tissue Chip Platform

BILLERICA, Mass.--(BUSINESS WIRE)--Javelin Biotech today announced a landmark scientific publication, titled "Interconnected multi-microphysiological systems and PBPK modeling for predicting human pharmacokinetics”, in the "Breakthrough" special issue of Lab on a Chip. The study details a liver-centric multi-tissue chip (MTC) platform designed to capture the complex pharmacokinetic (PK) profiles of small-molecule…

Business Wire • Jun 23, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for PK.

House Trades Disclosures

NameTransaction DateTypeAssetAmountLink

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top